Insiders Updates
IMNM Shares Experience Decline in Value
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Menu
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Immunome Inc’s filing revealed that its Director BIENAIME JEAN JACQUES acquired Company’s shares for reported $46900.0 on Jun 03 ’25.
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Immunome Inc’s recent filing unveils that its Director BIENAIME JEAN JACQUES acquired Company’s shares for reported $46900.0 on Jun 03
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Immunome Inc’s recent filing unveils that its Director BIENAIME JEAN JACQUES acquired Company’s shares for reported $46900.0 on Jun 03
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Immunome Inc’s filing revealed that its Director BIENAIME JEAN JACQUES acquired Company’s shares for reported $46900.0 on Jun 03 ’25.
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Immunome Inc’s filing revealed that its Director BIENAIME JEAN JACQUES acquired Company’s shares for reported $46900.0 on Jun 03 ’25.